The Medicare Part D coverage gap (donut hole) has been effectively eliminated thanks to the Inflation Reduction Act. Starting in 2025 and continuing in 2026, Medicare beneficiaries pay no more than $2,000 out of pocket for prescription drugs in a calendar year. This guide explains the current benefit structure, how the $2,000 cap works, and what has changed from the old donut hole system.
Key Facts
Check Your Specific Plan's Formulary
Coverage varies by plan. Use our formulary checker tool to look up your exact copay and restrictions.
Open Formulary CheckerFrequently Asked Questions
Effectively, yes. While the coverage phases technically still exist, the $2,000 annual out-of-pocket cap means you never pay more than $2,000 total for covered drugs in a year. The old donut hole could cost thousands in the gap. Now, once you reach $2,000, your plan covers everything at 100% for the rest of the year.
All your out-of-pocket spending on covered Part D drugs (copays, coinsurance, deductible payments) counts toward the $2,000 cap. Once your true out-of-pocket costs reach $2,000, you enter catastrophic coverage where your plan pays 100%. The Medicare Prescription Payment Plan lets you pay the $2,000 in equal monthly installments instead of all at once.
This optional program lets you spread your Part D out-of-pocket drug costs across the year in predictable monthly payments, similar to a payment plan. Instead of paying large copays at the pharmacy, you make equal monthly payments to your Part D plan. You can opt in at any time by contacting your plan.
Related Resources
- Medicare Part D Formulary 2026
- Medicare Advantage Formulary 2026
- Humana Formulary 2026
- Eliquis cash price comparison on RxGrab
- Jardiance cash price comparison on RxGrab
- Entresto cash price comparison on RxGrab
- Insulin cash price comparison on RxGrab
- Atorvastatin cash price comparison on RxGrab
- Drug interaction checker tool
- Patient assistance program finder
Get Formulary and Coverage Updates
Subscribe to receive alerts on formulary changes, new drug approvals, and insurance coverage updates.